Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
There are several factors to consider when evaluating abnormal sensations after starting Rybelsus, including timing, location, intensity, and impact on daily life. Mild, transient tingling or burning often responds to simple self care, but severe, spreading, or rapidly worsening symptoms like intense pain, new muscle weakness, or signs of infection are red flags that require prompt medical attention.
See below for the complete Dysaesthesia Checklist, detailed self care tips, and guidance on when and how to seek further help.
Starting a new medication can bring up questions about unusual sensations. Rybelsus (oral semaglutide) is a GLP-1 receptor agonist approved for type 2 diabetes. Most people tolerate it well, but some report new or worsening abnormal sensations—known as dysaesthesia—after starting. This guide helps you understand:
Use this checklist to track your symptoms, and remember to speak to a doctor about anything that could be life threatening or serious.
Dysaesthesia (pronounced dis-uh-THEE-zhuh) refers to unpleasant, abnormal sensations. Unlike simple numbness or tingling, it can feel like:
These sensations can affect the skin, mouth, hands, feet, or other areas.
Clinical trials and post-marketing reports for Rybelsus list common side effects such as:
Dysaesthesia-type symptoms are uncommon but have been reported anecdotally:
Because these complaints are infrequent, it's important to track timing, severity, and related factors.
Use this checklist to note your experience. Record details in a journal or notes app:
Onset Timing
Location
Description of Sensation
Daily Impact
Dose Correlation
Other Medications or Conditions
Most mild, short-lived nerve sensations improve on their own or with simple measures (cool compresses, topical creams). However, treat these as red flags:
If you check any of these boxes, seek medical attention promptly.
If your symptoms are mild and stable, you may try:
Keep a symptom diary and share it at your next medical visit.
If you're experiencing concerning symptoms and want personalized guidance before your appointment, try Ubie's free Medically Approved LLM Symptom Checker Chat Bot to help you understand what might be happening and when to seek care.
If your dysaesthesia is severe or you're unsure, speak to your prescribing doctor. They may:
Remember: always check with a healthcare provider before changing or stopping any prescribed medicine.
By staying informed and monitoring your symptoms carefully, you can address any concerns early and safely continue your diabetes management plan.
(References)
* Holst, J. J., Madsbad, S., & Kampmann, T. R. (2020). Semaglutide, a glucagon-like peptide-1 receptor agonist, for the treatment of type 2 diabetes. *Lancet Diabetes & Endocrinology*, *8*(1), 1-2.
* Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & STEP 1 Study Group. (2021). Once-weekly semaglutide in adults with overweight or obesity. *The New England Journal of Medicine*, *384*(11), 989-1002.
* Meier, J. J., & Nauck, M. A. (2015). GLP-1 receptor agonists in the treatment of type 2 diabetes. *Pharmacology & Therapeutics*, *145*, 1-24.
* Mahaffey, K. W., Gabriel, S., Pang, P. S., & Bakris, G. L. (2020). Renal and cardiovascular effects of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and chronic kidney disease: A systematic review and meta-analysis. *Diabetes, Obesity and Metabolism*, *22*(8), 1332-1342.
* Davies, M. J., Færch, K., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perner, B., ... & Lingvay, I. (2021). Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes: A PIONEER 4 trial randomized clinical trial. *Diabetes Care*, *44*(4), 947-957.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.